Indivior Pharmaceuticals, Inc. INDV FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's FX effect on cash?
- Indivior Pharmaceuticals, Inc. (INDV) reported FX effect on cash of $0 in Q1 2026.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's FX effect on cash?
- Over 2 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's FX effect on cash has grown at a 0.0% compound annual growth rate (CAGR), from -$1M to -$1M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.